Folate-mediated one-carbon metabolism and neural tube defects: Balancing genome synthesis and gene expression

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 81, Issue 3, 2007, Pages 183-203

  Beaudin, Anna E ^a   Stover, Patrick J ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXD PROTEIN; CARBON; CITED2 PROTEIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; MULTIVITAMIN; PROTEIN; TRANSCRIPTION FACTOR PAX3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 4; UNCLASSIFIED DRUG;

CARBON METABOLISM; EMBRYO DEVELOPMENT; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; GENE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME; GENOMICS; HUMAN; HYPERHOMOCYSTEINEMIA; METHYLATION; NEURAL TUBE DEFECT; NONHUMAN; NUCLEOTIDE METABOLISM; PREGNANCY; PRIORITY JOURNAL; REVIEW; VITAMIN SUPPLEMENTATION;

ANIMALS; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; GENE EXPRESSION; GENOME; HUMANS; MODELS, BIOLOGICAL; NEURAL TUBE DEFECTS; PERINATAL CARE; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE; RISK FACTORS; VARIATION (GENETICS);

EID: 36048983814     PISSN: 1542975X     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrc.20100     Document Type: Review

References (211)

1. Afman LA, Lievers KJ, Kluijtmans LA, et al. 2003. Gene-gene interaction between the cystathionine beta-synthase 31 base pair variable number of tandem repeats and the methylenetetrahydrofolate reductase 677C > T polymorphism on homocysteine levels and risk for neural tube defects. Mol Genet Metab 78:211-215.
2. Amur SG, Shanker G, Cochran JM, et al. 1986. Correlation between inhibition of myelin basic protein (arginine) methyltransferase by sinefungin and lack of compact myelin formation in cultures of cerebral cells from embryonic mice. J Neurosci Res 16:367-376.
3. Ananth CV, Elsasser DA, Kinzler WL, et al. 2007. Polymorphisms in methionine synthase reductase and betaine-homocysteine S-methyltransferase genes: risk of placental abruption. Mol Genet Metab 91:104-110.
4. Andersen S, Heine T, Sneve R, et al. 2005. Incorporation of dUMP into DNA is a major source of spontaneous DNA damage, while excision of uracil is not required for cytotoxicity of fluoropyrimidines in mouse embryonic fibroblasts. Carcinogenesis 26:547-555.
5. Anderson RG, Kamen BA, Rothberg KG, Lacey SW. 1992. Potocytosis: sequestration and transport of small molecules by caveolae. Science 255:410-411.
6. Appling DR. 1991. Compartmentation of folate-mediated one-carbon metabolism in eukaryotes. FASEB J 5:2645-2651.
7. Bai S, Ghoshal K, Datta J, et al. 2005. DNA methyltransferase 3b regulates nerve growth factor-induced differentiation of PC12 cells by recruiting histone deacetylase 2. Mol Cell Biol 25:751-766.
8. Bailey LB. 1995. Folate requirements and dietary recommendations. In: Bailey LB, editor. Folate in health and disease. New York: Marcel Dekker. pp. 123-152.
9. Bailey LB, Gregory JF 3rd. 1999. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr 129:919-922.
10. Barber RC, Shaw GM, Lammer EJ, et al. 1998. Lack of association between mutations in the folate receptor-alpha gene and spina bifida. Am J Med Genet 76:310-317.
11. Barber R, Shalat S, Hendricks K, et al. 2000. Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas Hispanic population. Mol Genet Metab 70:45-52.
12. Barbera JP, Rodriguez TA, Greene ND, et al. 2002. Folic acid prevents exencephaly in Cited2 deficient mice. Hum Mol Genet 11:283-293.
13. Barbosa PR, Stabler SP, Machado AL, et al. 2007. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women. Eur J Clin Nutr (in press)
14. Bennett GD, Vanwaes J, Moser K, et al. 2006. Failure of homocysteine to induce neural tube defects in a mouse model. Birth Defects Res B Dev Reprod Toxicol 77:89-94.
15. Blom HJ, Shaw GM, den Heijer M, Finnen RH. 2006. Neural tube defects and folate: case far from closed. Nat Rev Neurosci 7:724-731.
16. Blount BC, Mack MM, Wehr CM, et al. 1997. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94:3290-3295.
17. Boot MJ, Steegers-Theunissen RP, Poelmann RE, et al. 2003. Folic acid and homocysteine affect neural crest and neuroepithelial cell outgrowth and differentiation in vitro. Dev Dyn 227:301-308.
18. Botto LD, Yang Q. 2000. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862-877.
19. Bower C, Stanley FJ. 1989. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust 150:613-619.
20. Bowron A, Scott J, Stansbie D. 2005. The influence of genetic and environmental factors on plasma homocysteine concentrations in a population at high risk for coronary artery disease. Ann Clin Biochem 42(Pt 6):459-462.
21. Boyles AL, Billups AV, Deak KL, et al. 2006. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ Health Perspect 114:1547-1552.
22. Brauer PR, Tierney BJ. 2004. Consequences of elevated homocysteine during embryonic development and possible modes of action. Curr Pharm Des 10:2719-2732.
23. Brigle KE, Spinella MJ, Westin EH, Goldman ID. 1994. Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells. Biochem Pharmacol 47:337-345.
24. Brody LC, Conley M, Cox C, et al. 2002. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/ methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet 71:1207-1215.
25. Brown KS, Kluijtmans LA, Young IS, et al. 2004. The thymidylate synthase tandem repeat polymorphism is not associated with homocysteine concentrations in healthy young subjects. Hum Genet 114:182-185.
26. Bulut HE, Ozdemir O, Basimoglu-Koca Y, et al. 1999. Effects of a DNA demethylating agent-5-azacytidine - on testicular morphology during mouse embryo development. Okajimas Folia Anat Jpn 76:47-53.
27. Burgoon JM, Selhub J, Nadeau M, Sadler TW. 2002. Investigation of the effects of folate deficiency on embryonic development through the establishment of a folate deficient mouse model. Teratology 65:219-227.
28. CDC. 1992. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 41(RR-14):1-7.
29. Carter M, Ulrich S, Oofuji Y, et al. 1999. Crooked tail (Cd) models human folate-responsive neural tube defects. Hum Mol Genet 8:2199-2204.
30. Carter M, Chen X, Slowinska B, et al. 2005. Crooked tail (Cd) model of human folate-responsive neural tube defects is mutated in Wnt coreceptor lipoprotein receptor-related protein 6. Proc Natl Acad Sci USA 102:12843-12848.
31. Castro R, Rivera I, Ravasco P, et al. 2003. 5,10- Methylenetetrahydrofolate reductase 677C>T and 1298A>C mutations are genetic determinants of elevated homocysteine. QJM 96:297-303.
32. Chang TI, Horal M, Jain SK, et al. 2003. Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 46:538-545.
33. Chango A, Boisson F, Barbé F, Quillot D, Droesch S, Pfister M, Fillon-Emery N, Hampert D, Frémont S, Rosenblatt DS, Nicolas JP. 2000. The effect of 677C→T and 1298A→C mutations on plasma homosteine and 5.10-methylenetetrahydropolate reductase activity in healthy subjects. Br J Nutr 83:593-596.
34. Chango A, Emery-Fillon N, de Courcy GP, et al. 2000. A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 70:310-315.
35. Chen Z, Karaplis AC, Ackerman SL, et al. 2001. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 10:433-443.
36. Chen J, Ma J, Stampfer MJ, et al. 2002. Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenetics 12:339-342.
37. Christensen B, Arbour L, Tran P, et al. 1999. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 84:151-157.
38. Clarke S, Banfield K. 2001. S-adenosylmethionine-dependent methyltransferases. In: Carmel R, Jacobsen DW, editor. Homocysteine in health and disease. Cambridge: Cambridge University Press, pp. 63-78.
39. Cole BF, Baron JA, Sandler RS, et al. 2007. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297:2351-2359.
40. Copp AJ. 2005. Neurulation in the cranial region-normal and abnormal. J Anat 207:623-635.
41. Courtemanche C, Elson-Schwab I, Mashiyama ST, et al. 2004. Folate deficiency inhibits the proliferation of primary human CD8+ T lymphocytes in vitro. J Immunol 173:3186-3192.
42. Cusack SM, Rohn TT, Medeck RJ, et al. 2004. Suppression of MeCP2beta expression inhibits neurite extension in PC12 cells. Exp Cell Res 299:442-453.
43. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
44. De Marco P, Calevo MG, Moroni A, et al. 2002. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 47:319-324.
45. De Marco P, Merello E, Calevo MG, et al. 2006. Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G>A polymorphism for neural tube defect risk. J Hum Genet 51:98-103.
46. Doolin MT, Barbaux S, McDonnell M, et al. 2002. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 71:1222-1226.
47. Dunlevy LP, Burren KA, Chitty LS, et al. 2006a. Excess methionine suppresses the methylation cycle and inhibits neural tube closure in mouse embryos. FEBS Lett 580:2803-2807.
48. Dunlevy LP, Burren KA, Mills K, et al. 2006b. Integrity of the methylation cycle is essential for mammalian neural tube closure. Birth Defects Res A Clin Mol Teratol 76:544-552.
49. Dunlevy LP, Chitty LS, Burren KA, et al. 2007. Abnormal folate metabolism in foetuses affected by neural tube defects. Brain 130(Pt 4):1043-1049.
50. Elmore CL, Wu X, Ledere D, et al. 2007. Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase. Mol Genet Metab 91:85-97.
51. Engbersen AM, Franken DG, Boers GH, et al. 1995. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 56:142-150.
52. Epeldegui M, Pena-Melian A, Varela-Moreiras G, Perez-Miguelsanz J. 2002. Homocysteine modifies development of neurulation and dorsal root ganglia in chick embryos. Teratology 65:171-179.
53. Ernest S, Carter M, Shao H, et al. 2006. Parallel changes in metabolite and expression profiles in crooked-tail mutant and folate-reduced wild-type mice. Hum Mol Genet 15:3387-3393.
54. Essien FB, Wannberg SL. 1993. Methionine but not folinic acid or vitamin B-12 alters the frequency of neural tube defects in Axd mutant mice. J Nutr 123:27-34.
55. FDA. 1996. Final rule. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 61:8781-8797.
56. Finkelstein JD. 1998. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 157(Suppl 2):S40-S44.
57. Fisher MC, Zeisel SH, Mar MH, Sadler TW. 2002. Perturbations in choline metabolism cause neural tube defects in mouse embryos in vitro. FASEB J 16:619-621.
58. Fleming A, Copp AJ. 1998. Embryonic folate metabolism and mouse neural tube defects. Science 280:2107-2109.
59. Frandsen A, Schousboe A, Griffiths R. 1993. Cytotoxic actions and effects on intracellular Ca2+ and cGMP concentrations of sulphur-containing excitatory amino acids in cultured cerebral cortical neurons. J Neurosci Res 34:331-339.
60. Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, Mandel M, Kidron M, BarOn H. 1999. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: Association with plasma total homocysteine and folate concentrations. J Nutr 129:1656-1661.
61. Frosst P, Blom HJ, Milos R, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
62. Fuso A, Seminara L, Cavallaro RA, et al. 2005. S-adenosylmethionine/ homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol Cell Neurosci 28:195-204.
63. Girgis S, Suh JR, Jolivet J, Stover PJ. 1997. 5-Formyltetrahydrofolate regulates homocysteine remethylation in human neuroblastoma. J Biol Chem 272:4729-4734.
64. Gospe SM Jr, Gietzen DW, Summers PJ, et al. 1995. Behavioral and neurochemical changes in folate-deficient mice. Physiol Behav 58:935-941.
65. Grandone E, Corrao AM, Colaizzo D, et al. 2006. Homocysteine metabolism in families from southern Italy with neural tube defects: role of genetic and nutritional determinants. Prenat Diagn 26:1-5.
66. Green JM, MacKenzie RE, Matthews RG. 1988. Substrate flux through methylenetetrahydrofolate dehydrogenase: predicted effects of the concentration of methylenetetrahydrofolate on its partitioning into pathways leading to nucleotide biosynthesis or methionine regeneration. Biochemistry 27:8014-8022.
67. Greene ND, Dunlevy LE, Copp AJ. 2003. Homocysteine is embryotoxic but does not cause neural tube defects in mouse embryos. Anat Embryol (Berl) 206:185-191.
68. Gueant-Rodriguez RM, Rendeli C, Namour B, et al. 2003. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Lett 344:189-192.
69. Hansen DK, Grafton TF, Melnyk S, James SJ. 2001. Lack of embryotoxicity of homocysteine thiolactone in mouse embryos in vitro. Reprod Toxicol 15:239-244.
70. Harmon DL, Woodside JV, Yarnell JW, et al. 1996. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM 89:571-577.
71. Heid MK, Bills ND, Hinrichs SH, Clifford AJ. 1992. Folate deficiency alone does not produce neural tube defects in mice. J Nutr 122:888-894.
72. Heil SG, Van der Put NM, Waas ET, et al. 2001. Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab 73:164-172.
73. Herbig K, Chiang EP, Lee LR, et al. 2002. Cytoplasmic serine hydroxymethyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosyl-methionine biosyntheses. J Biol Chem 277:38381-38389.
74. Herrera E, Samper E, Blasco MA. 1999. Telomere shortening in mTR-/-embryos is associated with failure to close the neural tube. EMBO J 18:1172-1181.
75. Hibbard BM. 1964. The role of folic acid in pregnancy; with particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Commonw 71:529-542.
76. Hibbard BM. 1967. Defective folate metabolism in pathological conditions of pregnancy. Acta Obstet Gynecol Scand 46(Suppl 7):47-59.
77. Ho PI, Ortiz D, Rogers E, Shea TB. 2002. Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res 70:694-702.
78. Hoffman DR, Marion DW, Cornatzer WE, Duerre JA. 1980. S-Adenosylmethionine and S-adenosylhomocystein metabolism in isolated rat liver. Effects of L-methionine, L-homocystein, and adenosine. J Biol Chem 255:10822-10827.
79. Hollander MC, Sheikh MS, Bulavin DV, et al. 1999. Genomic instability in Gadd45a-deficient mice. Nat Genet 23:176-184.
80. Horie N, Aiba H, Oguro K, et al. 1995. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 20:191-197.
81. Huang RF, Huang SM, Lin BS, et al. 2001. Homocysteine thiolactone induces apoptotic DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation in HL-60 cells. Life Sci 68:2799-2811.
82. ICBDMS. 2000. Birth Defects Annual Report. International Clearinghouse for Birth Defects Monitoring Systems (ICBDMS), Rome.
83. IOM. 1998. Institute of Medicine. Folate. In: Dietary reference intakes for thiamin, riboflavin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academies Press, p 197.
84. Issaeva I, Zonis Y, Rozovskaia T, et al. 2007. Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Mol Cell Biol 27:1889-1903.
85. Jackson M, Krassowska A, Gilbert N, et al. 2004. Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells. Mol Cell Biol 24:8862-8871.
86. Jacques PF, Bostom AG, Williams RR, et al. 1996. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7-9.
87. Jacques PF, Bostom AG, Selhub J, et al. 2003. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atherosclerosis 166:49-55.
88. Jencks DA, Mathews RG. 1987. Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium. J Biol Chem 262:2485-2493.
89. Johnson WG, Stenroos ES, Spychala JR, et al. 2004. New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet A 124:339-345.
90. Juriloff DM, Harris MJ. 2000. Mouse models for neural tube closure defects. Hum Mol Genet 9:993-1000.
91. Kamen BA, Wang MT, Streckfuss AJ, et al. 1988. Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J Biol Chem 263:13602-13609.
92. Kanani PM, Sinkey CA, Browning RL, et al. 1999. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 100:1161-1168.
93. Kang SS, Wong PW, Zhou JM, et al. 1988. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism 37:611-613.
94. Kawakami K, Salonga D, Park JM, et al. 2001. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin Cancer Res 7:4096-4101.
95. Keller-Peck CR, Mullen RJ. 1997. Altered cell proliferation in the spinal cord of mouse neural tube mutants curly tail and Pax3 splotch-delayed. Brain Res Dev Brain Res 102:177-188.
96. Kim JK, Huh SO, Choi H, et al. 2001. Srg3, a mouse homolog of yeast SWI3, is essential for early embryogenesis and involved in brain development. Mol Cell Biol 21:7787-7795.
97. Kluijtmans LA, Young IS, Boreham CA, et al. 2003. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 101:2483-2488.
98. Kobayakawa S, Miike K, Nakao M, Abe K. 2007. Dynamic changes in the epigenomic state and nuclear organization of differentiating mouse embryonic stem cells. Genes Cells 12:447-460.
99. Kruman II, Culmsee C, Chan SL, et al. 2000. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20:6920-6926.
100. Kutzbach C, Stokstad EL. 1971. Mammalian methylenetetrahydrofolate reductase. Partial purification, properties, and inhibition by S-adenosylmethionine. Biochim Biophys Acta 250:459-477.
101. Lee CC, Surtees R, Duchen LW. 1992. Distal motor axonopathy and central nervous system myelin vacuolation caused by cycloleucine, an inhibitor of methionine adenosyltransferase. Brain 115(Pt 3):935-955.
102. Li D, Pickell L, Liu Y, et al. 2005a. Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice. Am J Clin Nutr 82:188-195.
103. Li R, Chase M, Jung SK, et al. 2005b. Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab 289:E591-E599.
104. Lievers KJ, Kluijtmans LA, Heil SG, et al. 2001. A 31 bp VNTR in the cystathionine beta-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels. Eur J Hum Genet 9:583-589.
105. Lin BF, Shane B. 1994. Expression of Escherichia coli folylpolyglutamate synthetase in the Chinese hamster ovary cell mitochondrion. J Biol Chem 269:9705-9713.
106. Linnebank M, Hornberger A, Nowak-Gottl U, et al. 2000. Linkage disequilibrium of the common mutations 677C > T and 1298A > C of the human methylenetetrahydrofolate reductase gene as proven by the novel polymorphisms 129C > T, 1068C > T. Eur J Pediatr 159:472-473.
107. Upton SA, Kim WK, Choi YB, et al. 1997. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 94:5923-5928.
108. Lucock M, Daskalakis I, Briggs D, et al. 2000. Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677c > t methylenetetrahydrofolate reductase and 2756a > g methionine synthase genotypes. Mol Genet Metab 70:27-44.
109. MRC. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study.MRC Vitamin Study Research Group. Lancet 338:131-137.
110. Ma J, Stampfer MJ, Giovannucci E, et al. 1997. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57:1098-1102.
111. Maddox DM, Manlapat A, Roon P, et al. 2003. Reduced-folate carrier (RFC) is expressed in placenta and yolk sac, as well as in cells of the developing forebrain, hindbrain, neural tube, craniofacial region, eye, limb buds and heart. BMC Dev Biol 3:6.
112. Malinow MR, Nieto FJ, Kruger WD, et al. 1997. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 17:1157-1162.
113. Martinez de Villarreal LE, Delgado-Enciso I, Valdez-Leal R, et al. 2001. Folate levels and N(5),N(10)-methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study. Arch Med Res 32:277-282.
114. McKay JA, Williams EA, Mathers JC. 2004. Folate and DNA methylation during in utero development and aging. Biochem Soc Trans 32(Pt 6):1006-1007.
115. Mills JL, McPartlin JM, Kirke PN, et al. 1995. Homocysteine metabolism in pregnancies complicated by neuraltube defects. Lancet 345:149-151.
116. Mills JL, Signore C. 2004. Neural tube defect rates before and after food fortification with folic acid. Birth Defects Res A Clin Mol Teratol 70:844-845.
117. Milunsky A, Jick H, Jick SS, et al. 1989. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262:2847-2852.
118. Mitchell LE, Adzick NS, Melchionne J, et al. 2004. Spina bifida. Lancet 364:1885-1895.
119. Molloy AM, Mills JL, Kirke PN, et al. 1998. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10- methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am J Med Genet 78:155-159.
120. Morin I, Devlin AM, Leclerc D, et al. 2003a. Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk. Mol Genet Metab 79:197-200.
121. Morin I, Piatt R, Weisberg I, etal. 2003b. Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Am J Med Genet A 119:172-176.
122. Mornet E, Muller F, Lenvoise-Furet A, et al. 1997. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 100:512-514.
123. Morrison K, Edwards YH, Lynch SA, et al. 1997. Methionine synthase and neural tube defects. J Med Genet 34:958.
124. Morrison K, Papapetrou C, Hol FA, et al. 1998. Susceptibility to spina bifida; an association study of five candidate genes. Ann Hum Genet 62(Pt 5):379-396.
125. Mudd S, Levy H, Skovby F. 1989. Disorders of transsulfuration. In: Scriver CR, Beaudet A, Sly WS, Valle D, editors. The metabolic basis of inherited disease. 6th ed. New York: McGraw-Hill, Inc. pp. 693-734.
126. Mulinare J, Cordero JF, Erickson JD, Berry RJ. 1988. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 260:3141-3145.
127. Namihira M, Nakashima K, Taga T. 2004. Developmental stage dependent regulation of DNA methylation and chromatin modification in a immature astrocyte specific gene promoter. FEBS Lett 572:184-188.
128. Nieto MA, Sargent MG, Wilkinson DG, Cooke J. 1994. Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 264:835-839.
129. O'Leary VB, Mills JL, Kirke PN, et al. 2003. Analysis of the human folate receptor beta gene for an association with neural tube defects. Mol Genet Metab 79:129-133.
130. O'Leary VB, Mills JL, Pangilinan F, et al. 2005. Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. Mol Genet Metab 85:220-227.
131. Okada G, Teraoka H, Tsukada K. 1981. Multiple species of mammalian S-adenosylmethionine synthetase. Partial purification and characterization. Biochemistry 20:934-940.
132. Ou CY, Stevenson RE, Brown VK, et al. 1996. 5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 63:610-614.
133. Papapetrou C, Lynch SA, Burn J, Edwards YH. 1996. Methylenetetrahydrofolate reductase and neural tube defects. Lancet 348:58.
134. Parle-McDermott A, Mills JL, Kirke PN, et al. 2003. Analysis of the MTHFR 1298A>C and 677C>T polymorphisms as risk factors for neural tube defects. J Hum Genet 48:190-193.
135. Parle-McDermott A, Kirke PN, Mills JL, et al. 2006. Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population. Eur J Hum Genet 14:768-772.
136. Parle-McDermott A, Pangilinan F, Mills JL, et al. 2007. The 19-bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population. Am J Med Genet A 143:1174-1180.
137. Pei L, Zhu H, Ren A, et al. 2005. Reduced folate carrier gene is a risk factor for neural tube defects in a Chinese population. Birth Defects Res A Clin Mol Teratol 73:430-433.
138. Piedrahita JA, Oetama B, Bennett GD, et al. 1999. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat Genet 23:228-232.
139. Qiu A, Jansen M, Sakaris A, et al. 2006. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127:917-928.
140. Quere I, Paul V, Rouillac C, et al. 1999. Spatial and temporal expression of the cystathionine beta-synthase gene during early human development. Biochem Biophys Res Commun 254:127-137.
141. Quinlivan EP, Davis SR, Shelnutt KP, et al. 2005. Methylenetetrahydrofolate reductase 677C->T polymorphism and folate status affect one-carbon incorporation into human DNA deoxynucleosides. J Nutr 135:389-396.
142. Rahnama F, Shafiei F, Gluckman PD, et al. 2006. Epigenetic regulation of human trophoblastic cell migration and invasion. Endocrinology 147:5275-5283.
143. Rampersaud E, Melvin EC, Siegel D, et al. 2003. Updated investigations of the role of methylenetetrahydrofolate reductase in human neural tube defects. Clin Genet 63:210-214.
144. Ray JG, Blom HJ. 2003. Vitamin B12 insufficiency and the risk of fetal neural tube defects. QJM 96:289-295.
145. Relton CL, Wilding CS, Laffling AJ, et al. 2004a. Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. Mol Genet Metab 81:273-281.
146. Relton CL, Wilding CS, Pearce MS, et al. 2004b. Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 41:256-260.
147. Richter B, Stegmann K, Roper B, et al. 2001. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population. J Hum Genet 46:105-109.
148. Robert K, Vialard F, Thiery E, et al. 2003. Expression of the cystathionine beta synthase (CBS) gene during mouse development and immunolocalization in adult brain. J Histochem Cytochem 51:363-371.
149. Rosenquist TH, Ratashak SA, Selhub J. 1996. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA 93:15227-15232.
150. Saitsu H, Ishibashi M, Nakano H, Shiota K. 2003. Spatial and temporal expression of folate-binding protein 1 (Fbp1) is closely associated with anterior neural tube closure in mice. Dev Dyn 226:112-117.
151. Schirch V, Strong WB. 1989. Interaction of folylpolyglutamates with enzymes in one-carbon metabolism. Arch Biochem Biophys 269:371-380.
152. Scott JM, Dinn JJ, Wilson P, Weir DG. 1981. Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet 2:334-337.
153. Sebastio G, Sperandeo MP, Panico M, et al. 1995. The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations. Am J Hum Genet 56:1324-1333.
154. Seller MJ, Nevin NC. 1984. Periconceptional vitamin supplementation and the prevention of neural tube defects in south-east England and Northern Ireland. J Med Genet 21:325-330.
155. Shane B. 1989. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam Horm 45:263-335.
156. Shane B. 1995. Folate chemistry and metabolism. In: Bailey LP, editor. Folate in health and disease. New York: Marcel Dekker. pp. 1-22.
157. Shaw GM, Schaffer D, Velie EM, et al. 1995. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6:219-226.
158. Shaw GM, Lammer EJ, Zhu H, et al. 2002. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet 108:1-6.
159. Shi M, Caprau D, Romitti P, et al. 2003. Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genes MTHFR, MTHFD, MTRR, RFC1, and GCP2. Birth Defects Res A Clin Mol Teratol 67:545-549.
160. Shields DC, Kirke PN, Mills JL, et al. 1999. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64:1045-1055.
161. Shilatifard A. 2006. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem 75:243-269.
162. Smithells R, Sheppard S, Schorah J. 1976. Vitamin deficiency and neural tube defects. Arch Dis Child 51:944-950.
163. Smithells RW, Nevin NC, Seller MJ, et al. 1983. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1:1027-1031.
164. Speer MC, Nye J, McLone D, et al. 1999. Possible interaction of genotypes at cystathionine beta-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects.NTD Collaborative Group. Clin Genet 56:142-144.
165. Steegers-Theunissen RP, Boers GH, Trijbels FJ, Eskes TK. 1991. Neuraltube defects and derangement of homocysteine metabolism. N Engl J Med 324:199-200.
166. Stegmann K, Ziegler A, Ngo ET, et al. 1999. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects(NTD). Am J Med Genet 87:23-29.
167. Stover PJ, Garza C. 2002. Bringing individuality to public health recommendations. J Nutr 132(8 Suppl):2476S-2480S.
168. Stover PJ. 2004. Physiology of folate and vitamin B12 in health and disease. Nutr Rev 62(Pt 2):S3-S12; discussion S13.
169. Suh JR, Herbig AK, Stover PJ. 2001. New perspectives on folate catabolism. Annu Rev Nutr 21:255-282.
170. Sunden SL, Renduchintala MS, Park EI, et al. 1997. Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. Arch Biochem Biophys 345:171-174.
171. Swanson DA, Liu ML, Baker PJ, et al. 2001. Targeted disruption of the methionine synthase gene in mice. Mol Cell Biol 21:1058-1065.
172. Tamura T, Stokstad EL. 1973. The availability of food folate in man. Br J
173. Tierney BJ, Ho T, Reedy MV, Brauer PR. 2004. Homocysteine inhibits cardiac neural crest cell formation and morphogenesis in vivo. Dev Dyn 229:63-73.
174. Topal G, Brunet A, Millanvoye E, et al. 2004. Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. Free Radic Biol Med 36:1532-1541.
175. Trinh BN, Ong CN, Coetzee GA, et al. 2002. Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet 111:299-302.
176. Troen AM, Mitchell B, Sorensen B, et al. 2006. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr 136:189-194.
177. Turek-Plewa J, Jagodzinski PP. 2005. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett 10:631-647.
178. van der Linden IJ, Afman LA, Heil SG, Blom HJ. 2006a. Genetic variation in genes of folate metabolism and neural-tube defect risk. Proc Nutr Soc 65:204-215.
179. van der Linden IJ, den Heijer M, Afman LA, et al. 2006b. The methionine synthase reductase 66A>G polymorphism is a maternal risk factor for spina bifida. J Mol Med 84:1047-1054.
180. van der Linden IJ, Nguyen U, Heil SG, et al. 2007. Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida. Mol Genet Metab 91:98-103.
181. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
182. van der Put NM, van den Heuvel LP, Steegers-Theunissen RP, et al. 1996. Decreased methylene tetrahydrofolate reductase activity due to the 677C>T mutation in families with spina bifida offspring. J Mol Med 74:691-694.
183. van der Put NM, Eskes TK, Blom HJ. 1997a. Is the common 677C>T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. QJM 90:111-115.
184. van der Put NM, van der Molen EF, Kluijtmans LA, et al. 1997b. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. QJM 90:511-517.
185. van der Put NMJ, Gabreel SF, Stevans EMB, Smetink JAM, Trijbels FJM, Eskes TK, van den Heuvel LP, Blom HJ. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural tube defects? Am J Hum Genet 62.
186. Vergel RG, Sanchez LR, Heredero BL, et al. 1990. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 10:149-152.
187. Visvader J, Adams JM. 1993. Megakaryocyte differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression. Blood 82:1493-1501.
188. Volcik KA, Shaw GM, Lammer EJ, et al. 2003a. Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects. Birth Defects Res A Clin Mol Teratol 67:154-157.
189. Volcik KA, Shaw GM, Zhu H, et al. 2003b. Associations between polymorphisms within the thymidylate synthase gene and spina bifida. Birth Defects Res A Clin Mol Teratol 67:924-928.
190. Wagner C. 1995. Biochemical role of folate in cellular metabolism. In: Bailey LP, editor. Folate in health and disease. New York: Marcel Dekker. pp. 23-42.
191. Wang X, Shen F, Freisheim JH, et al. 1992. Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates. Biochem Pharmacol 44:1898-1901.
192. Wang X, Wang RH, Li W, et al. 2004. Genetic interactions between Brca1 and Gadd45a in centrosome duplication, genetic stability, and neural tube closure. J Biol Chem 279:29606-29614.
193. Watanabe M, Osada J, Aratani Y, et al. 1995. Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci USA 92:1585-1589.
194. Waterland RA, Lin JR, Smith CA, Jirtle RL. 2006. Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus. Hum Mol Genet 15:705-716.
195. Weisberg IS, Park E, Ballman KV, et al. 2003. Investigations of a common genetic variant in betaine-homocysteine methyltransferase (BHMT) in coronary artery disease. Atherosclerosis 167:205-214.
196. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. 1998. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169-172.
197. Weiss N, Heydrick S, Zhang YY, et al. 2002. Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice. Arterioscler Thromb Vasc Biol 22:34-41.
198. Whitehead AS, Gallagher P, Mills JL, et al. 1995. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM 88:763-766.
199. Wilding CS, Relton CL, Sutton MJ, et al. 2004. Thymidylate synthase repeat polymorphisms and risk of neural tube defects in a population from the northern United Kingdom. Birth Defects Res A Clin Mol Teratol 70:483-485.
200. Wlodarczyk BJ, Tang LS, Triplett A, et al. 2006. Spontaneous neural tube defects in splotch mice supplemented with selected micronutrients. Toxicol Appl Pharmacol 213:55-63.
201. Woeller CF, Anderson DD, Szebenyi DM, Stover PJ. 2007. Evidence for small ubiquitin-like modifier-dependent nuclear import of the thymidylate biosynthesis pathway. J Biol Chem 282:17623-17631.
202. Wolff GL, Kodell RL, Moore SR, Cooney CA. 1998. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 12:949-957.
203. Yang F, Hanson NQ, Schwichtenberg K, Tsai MY. 2000. Variable number tandem repeat in exon/intron border of the cystathionine beta-synthase gene: a single nucleotide substitution in the second repeat prevents multiple alternate splicing. Am J Med Genet 95:385-390.
204. Yates JR, Ferguson-Smith MA, Shenkin A, et al. 1987. Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects? Clin Genet 31:279-287.
205. Zagris N, Podimatas T. 1994. 5-Azacytidine changes gene expression and causes developmental arrest of early chick embryo. Int J Dev Biol 38:741-744.
206. Zhao Q, Behringer RR, de Crombrugghe B. 1996. Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart1 homeobox gene. Nat Genet 13:275-283.
207. Zhao R, Russell RG, Wang Y, et al. 2001. Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs. J Biol Chem 276:10224-10228.
208. Zhao X, Ueba T, Christie BR, et al. 2003. Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proc Natl Acad Sci USA 100:6777-6782.
209. Zhu H, Wicker NJ, Shaw GM, et al. 2003. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab 78:216-221.
210. Zhu H, Curry S, Wen S, et al. 2005. Are the betaine-homocysteine methyltransferase (BHMT and BHMT2) genes risk factors for spina bifida and orofacial clefts? Am J Med Genet A 135:274-277.
211. Zittoun J, Tonetti C, Bories D, et al. 1998. Plasma homocysteine levels related to interactions between folate status and methylenetetrahydrofolate reductase: a study in 52 healthy subjects. Metabolism 47:1413-1418.